Can a short, High-Dose radiation blast before surgery improve breast cancer care?

NCT ID NCT04360330

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial is testing a new way to deliver radiation therapy for early-stage breast cancer. Instead of the usual weeks of daily radiation after surgery, this approach gives a shorter, more intense course of radiation before the tumor is removed. The study aims to find the safest and most effective dose of this preoperative radiation, called SABER, in women aged 50 and older with a specific type of early-stage breast cancer. By giving radiation before surgery, doctors hope to potentially improve treatment outcomes and reduce the overall treatment time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Stereotactic Ablative Breast Radiotherapy (SABER)
What this could lead to
If successful, this could lead to a shorter, more effective radiation treatment before surgery for early-stage breast cancer, potentially improving outcomes and reducing side effects.
What could go wrong
This is an early-phase trial with a small number of participants, so the optimal dose and safety profile are still being determined. There is a risk of radiation-related side effects, and the approach may not prove better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Miami

    RECRUITING

    Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.